Brooks Laboratories Limited (NSE:BROOKS)
India · Delayed Price · Currency is INR 155.00
-1.21 (-0.77%)
Aug 14, 2025, 11:26 AM IST
Brooks Laboratories Market Cap
Brooks Laboratories has a market cap or net worth of 4.65 billion as of August 13, 2025. Its market cap has increased by 94.79% in one year.
Market Cap
4.65B
Enterprise Value
4.72B
Revenue
902.84M
Ranking
n/a
PE Ratio
213.39
Stock Price
155.00
Market Cap Chart
Since September 5, 2011, Brooks Laboratories's market cap has increased from 105.21M to 4.65B, an increase of 4,321.54%. That is a compound annual growth rate of 31.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 4.65B | -1.61% |
| Dec 31, 2024 | 4.73B | 25.45% |
| Dec 29, 2023 | 3.77B | 39.59% |
| Dec 30, 2022 | 2.70B | 8.92% |
| Dec 31, 2021 | 2.48B | 51.02% |
| Dec 31, 2020 | 1.64B | 232.25% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,859.09B |
| Divi's Laboratories | 1,590.69B |
| Cipla | 1,215.50B |
| Apollo Hospitals Enterprise | 1,043.73B |
| Mankind Pharma | 1,006.03B |
| Zydus Lifesciences | 961.51B |
| Fortis Healthcare | 695.05B |
| Aurobindo Pharma | 611.53B |